| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 1, 2025 | Buy(P) | 20K | $0.59 | $12K | 992K |
| Mar 31, 2025 | Buy(P) | 22K | $0.59 | $13K | 972K |
| Mar 28, 2025 | Buy(P) | 49K | $0.61 | $30K | 950K |
| Mar 27, 2025 | Buy(P) | 600 | $0.61 | $366 | 901K |
| Mar 27, 2025 | Buy(P) | 19K | $0.62 | $11K | 900K |
| Mar 26, 2025 | Buy(P) | 13K | $0.61 | $8K | 881K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001398344-25-007146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NovaBay Pharmaceuticals, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001398344-25-007146"
Use Arkolith to summarize insider buying and selling at NovaBay Pharmaceuticals, Inc. over the last 90 days and cite the filings.